Zafrens
PrivateLast Round
Series A
Feb 4, 2025
Total Funding Raised
$71.16M
Company Overview
Zafrens is a biotechnology company that develops an ultra-high throughput platform for single-cell analysis and drug discovery by integrating biology, chemistry, and engineering.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zafrens Comparables
Compare Zafrens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Singleron Biotechnologies | 77% | |
| Mission Bio | 76% | |
| Bruker | 72% |
Zafrens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 4, 2025 | ||||
| Series A | Dec 11, 2023 | ||||
| Seed | Dec 30, 2021 |
Zafrens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iaso Ventures | Series A |
| KOFA Healthcare | Series A |
| BlueYard Capital | Series A |
| FoundersX Ventures | Series A |
| Global Brain Corporation | Series A |
| Alix Ventures | Series A |
| Hawktail Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 4, 2025
$31M round with participation from BlueYard Capital and others.
- Dec 11, 2023
$31M round led by Prime Movers Lab.
Zafrens Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Zafrens's valuation, stock price, and market status.
Is Zafrens a public or private company?
Zafrens is a private company.
What is the current stock price of Zafrens?
Zafrens is a private company with no public stock price. No recent secondary market data is available.
How much is Zafrens worth (valuation)?
Valuation information for Zafrens is not publicly available.
Can I buy Zafrens stock?
Zafrens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Zafrens's last funding round?
Zafrens's most recent funding round was Series A on February 4, 2025.
Who are the main investors in Zafrens?
Key investors in Zafrens include Prime Movers Lab.
Will Zafrens IPO soon?
No public IPO plans have been announced for Zafrens.
How can I track Zafrens secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zafrens's secondary market activity and sign up for updates.